Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
November-2018 Volume 42 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2018 Volume 42 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Inhibition of Cx43 attenuates ERK1/2 activation, enhances the expression of Cav‑1 and suppresses cell proliferation

  • Authors:
    • Muhammad Arshad
    • Charlotte Conzelmann
    • Muhammad Assad Riaz
    • Thomas Noll
    • Dursun Gündüz
  • View Affiliations / Copyright

    Affiliations: Department of Cardiology and Angiology, University Hospital Giessen and Marburg, D‑35392 Giessen, Germany, Department of Radiotherapy, University Hospital Essen, D‑45147 Essen, Germany, Institute of Physiology, Carl Gustav Carus Technical University of Dresden, D‑01307 Dresden, Germany
  • Pages: 2811-2818
    |
    Published online on: August 16, 2018
       https://doi.org/10.3892/ijmm.2018.3828
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

In addition to being an important component of the gap junction, connexin 43 (Cx43) has been shown to regulate other cellular functions, including cell proliferation. This regulatory role of Cx43 may be important in therapeutic situations, including wound healing or ischemic injuries. Caveolin‑1 (Cav‑1) has been shown to regulate angiogenesis. The aim of the present study was to analyze whether Cx43 counter‑regulates Cav‑1 in controlling the proliferation and migration of endothelial cells. The inhibition of Cx43 with niflumic acid, flufenamic acid and 18‑α‑glycyrrhetinic acid in cultured human umbilical vein endothelial cells resulted in decreased phosphorylation of extracellular signal‑regulated kinase (ERK)1/2 and increased expression of Cav‑1, as shown by western blot analysis. Furthermore, the inhibition of Cx43 resulted in a 50±7% decrease in cell proliferation, determined using a crystal violet assay, a 48±5% decrease in migration, determined using a migration assay, and a 49±6% decrease in endothelial tube formation, determined using a Matrigel assay, compared with the control. Similar results were obtained following specific inhibition of Cx43 by mimetic peptides (Gap26 and Gap27). Inhibition of the mitogen‑activated protein kinase kinase/ERK pathway with PD‑98059 resulted in an increased expression of Cav‑1 and a reduction in the expression of Cx43. Furthermore, cell proliferation, migration and tube formation in endothelial cells were impaired. By contrast, downregulation of the protein expression of Cav‑1 by small interference RNA resulted in increased expression of Cx43 and phosphorylation of ERK1/2. Accordingly, the number of cells in the Cav‑1 treated‑group increased by 35±5% compared with the controls. The data of the present study showed that Cav‑1 suppressed cell proliferation by inhibiting the activity of Cx43, which is upstream of ERK1/2. The downregulation of Cav‑1 protein resulted in loss of the inhibitory activity of Cav‑1 on cell proliferation and led to increased cell proliferation. This counter‑regulatory effect of Cx43 may be of importance in therapeutic angiogenesis.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Carmeliet P: Angiogenesis in life, disease and medicine. Nature. 438:932–936. 2005. View Article : Google Scholar : PubMed/NCBI

2 

Augustin HG: Tubes, branches, and pillars: The many ways of forming a new vasculature. Circ Res. 89:645–647. 2001. View Article : Google Scholar : PubMed/NCBI

3 

Larson DM and Haudenschild CC: Junctional transfer in wounded cultures of bovine aortic endothelial cells. Lab Invest. 59:373–379. 1988.PubMed/NCBI

4 

Homkajorn B, Sims NR and Muyderman H: Connexin 43 regulates astrocytic migration and proliferation in response to injury. Neurosci Lett. 486:197–201. 2010. View Article : Google Scholar : PubMed/NCBI

5 

Walker DL, Vacha SJ, Kirby ML and Lo CW: Connexin43 deficiency causes dysregulation of coronary vasculogenesis. Dev Biol. 284:479–498. 2005. View Article : Google Scholar : PubMed/NCBI

6 

Vinken M, Decrock E, De Vuyst E, Ponsaerts R, D'hondt C, Bultynck G, Ceelen L, Vanhaecke T, Leybaert L and Rogiers V: Connexins: Sensors and regulators of cell cycling. Biochim Biophys Acta. 1815:13–25. 2011.

7 

Stains JP and Civitelli R: Gap junctions regulate extracellular signal-regulated kinase signaling to affect gene transcription. Mol Biol Cell. 16:64–72. 2005. View Article : Google Scholar :

8 

Gomes P, Srinivas SP, Vereecke J and Himpens B: ATP-dependent paracrine intercellular communication in cultured bovine corneal endothelial cells. Invest Ophthalmol Vis Sci. 46:104–113. 2005. View Article : Google Scholar

9 

Faigle M, Seessle J, Zug S, El Kasmi KC and Eltzschig HK: ATP release from vascular endothelia occurs across Cx43 hemichannels and is attenuated during hypoxia. PloS One. 3:e28012008. View Article : Google Scholar : PubMed/NCBI

10 

Brisset AC, Isakson BE and Kwak BR: Connexins in vascular physiology and pathology. Antioxid Redox Signal. 11:267–282. 2009. View Article : Google Scholar

11 

Goodenough DA, Goliger JA and Paul DL: Connexins, connexons, and intercellular communication. Annu Rev Biochem. 65:475–502. 1996. View Article : Google Scholar : PubMed/NCBI

12 

Söhl G and Willecke K: Gap junctions and the connexin protein family. Cardiovasc Res. 62:228–232. 2004. View Article : Google Scholar : PubMed/NCBI

13 

Hervé JC and Derangeon M: Gap-junction-mediated cell-to-cell communication. Cell Tissue Res. 352:21–31. 2013. View Article : Google Scholar

14 

Bruzzone R, White TW and Paul DL: Connections with connexins: The molecular basis of direct intercellular signaling. Eur J Biochem. 238:1–27. 1996. View Article : Google Scholar : PubMed/NCBI

15 

Maeda S and Tsukihara T: Structure of the gap junction channel and its implications for its biological functions. Cell Mol Life Sci. 68:1115–1129. 2011. View Article : Google Scholar

16 

Haefliger JA, Nicod P and Meda P: Contribution of connexins to the function of the vascular wall. Cardiovasc Res. 62:345–356. 2004. View Article : Google Scholar : PubMed/NCBI

17 

Van Rijen H, van Kempen MJ, Analbers LJ, Rook MB, van Ginneken AC, Gros D and Jongsma HJ: Gap junctions in human umbilical cord endothelial cells contain multiple connexins. Am J Physiol. 272:C117–C130. 1997. View Article : Google Scholar : PubMed/NCBI

18 

Wang HH, Kung CI, Tseng YY, Lin YC, Chen CH, Tsai CH and Yeh HI: Activation of endothelial cells to pathological status by down-regulation of connexin43. Cardiovasc Res. 79:509–518. 2008. View Article : Google Scholar : PubMed/NCBI

19 

Dhein S, Gaertner C, Georgieff C, Salameh A, Schlegel F and Mohr FW: Effects of isoprenaline on endothelial connexins and angiogenesis in a human endothelial cell culture system. Naunyn Schmiedebergs Arch Pharmacol. 388:101–108. 2015. View Article : Google Scholar

20 

Wang HH, Su CH, Wu YJ, Li JY, Tseng YM, Lin YC, Hsieh CL, Tsai CH and Yeh HI: Reduction of connexin43 in human endothelial progenitor cells impairs the angiogenic potential. Angiogenesis. 16:553–560. 2013. View Article : Google Scholar : PubMed/NCBI

21 

Xu X, Francis R, Wei CJ, Linask KL and Lo CW: Connexin 43-mediated modulation of polarized cell movement and the directional migration of cardiac neural crest cells. Development. 133:3629–3639. 2006. View Article : Google Scholar : PubMed/NCBI

22 

Kardami E, Stoski RM, Doble BW, Yamamoto T, Hertzberg EL and Nagy JI: Biochemical and ultrastructural evidence for the association of basic fibroblast growth factor with cardiac gap junctions. J Biol Chem. 266:19551–19557. 1991.PubMed/NCBI

23 

Gartner C, Ziegelhöffer B, Kostelka M, Stepan H, Mohr FW and Dhein S: Knock-down of endothelial connexins impairs angio-genesis. Pharmacol Res. 65:347–357. 2012. View Article : Google Scholar

24 

Polontchouk L, Ebelt B, Jackels M and Dhein S: Chronic effects of endothelin 1 and angiotensin II on gap junctions and intercellular communication in cardiac cells. FASEB J. 16:87–89. 2002. View Article : Google Scholar

25 

Schulz R, Görge PM, Gorbe A, Ferdinandy P, Lampe PD and Leybaert L: Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuropro-tection. Pharmacol Ther. 153:90–106. 2015. View Article : Google Scholar : PubMed/NCBI

26 

Bian B, Yu X, Wang Q, Teng T and Nie J: Atorvastatin protects myocardium against ischemia-reperfusion arrhythmia by increasing Connexin 43 expression: A rat model. Eur J Pharmacol. 768:13–20. 2015. View Article : Google Scholar : PubMed/NCBI

27 

Strale PO, Clarhaut J, Lamiche C, Cronier L, Mesnil M and Defamie N: Down-regulation of Connexin43 expression reveals the involvement of caveolin-1 containing lipid rafts in human U251 glioblastoma cell invasion. Mol Carcinog. 51:845–860. 2012. View Article : Google Scholar

28 

Wang WK, Chen MC, Leong HF, Kuo YL, Kuo CY and Lee CH: Connexin 43 suppresses tumor angiogenesis by down-regulation of vascular endothelial growth factor via hypoxic-induced factor-1α. Int J Mol Sci. 16:439–451. 2014. View Article : Google Scholar : PubMed/NCBI

29 

Kwak BR, Mulhaupt F, Veillard N, Gros DB and Mach F: Altered pattern of vascular connexin expression in atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 22:225–230. 2002. View Article : Google Scholar : PubMed/NCBI

30 

Chadjichristos CE, Derouette JP and Kwak BR: Connexins in atherosclerosis. Adv Cardiol. 42:255–267. 2006. View Article : Google Scholar : PubMed/NCBI

31 

Li H, He J, Yu H, Green CR and Chang J: Bioglass promotes wound healing by affecting gap junction connexin 43 mediated endothelial cell behavior. Biomaterials. 84:64–75. 2016. View Article : Google Scholar : PubMed/NCBI

32 

Tarzemany R, Jiang G, Jiang JX, Gallant-Behm C, Wiebe C, Hart DA, Larjava H and Häkkinen L: Connexin 43 regulates the expression of wound healing-related genes in human gingival and skin fibroblasts. Exp Cell Res. 367:150–161. 2018. View Article : Google Scholar : PubMed/NCBI

33 

Fang K, Fu W, Beardsley AR, Sun X, Lisanti MP and Liu J: Overexpression of caveolin-1 inhibits endothelial cell proliferation by arresting the cell cycle at G0/G1 phase. Cell Cycle. 6:199–204. 2007. View Article : Google Scholar : PubMed/NCBI

34 

Lin MI, Yu J, Murata T and Sessa WC: Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth. Cancer Res. 67:2849–2856. 2007. View Article : Google Scholar : PubMed/NCBI

35 

Sotkis A, Wang XG, Yasumura T, Peracchia LL, Persechini A, Rash JE and Peracchia C: Calmodulin colocalizes with connexins and plays a direct role in gap junction channel gating. Cell Commun Adhes. 8:277–281. 2001. View Article : Google Scholar

36 

Giepmans BN, Verlaan I, Hengeveld T, Janssen H, Calafat J, Falk MM and Moolenaar WH: Gap junction protein connexin-43 interacts directly with microtubules. Curr Biol. 11:1364–1368. 2001. View Article : Google Scholar : PubMed/NCBI

37 

Schubert AL, Schubert W, Spray DC and Lisanti MP: Connexin family members target to lipid raft domains and interact with caveolin-1. Biochemistry. 41:5754–5764. 2002. View Article : Google Scholar : PubMed/NCBI

38 

Langlois S, Cowan KN, Shao Q, Cowan BJ and Laird DW: Caveolin-1 and -2 interact with connexin43 and regulate gap junctional intercellular communication in keratinocytes. Mol Biol Cell. 19:912–928. 2008. View Article : Google Scholar :

39 

Razani B, Schlegel A, Liu J and Lisanti MP: Caveolin-1, a putative tumour suppressor gene. Biochem Soc Trans. 29:494–499. 2001. View Article : Google Scholar : PubMed/NCBI

40 

Galbiati F, Volonté D, Liu J, Capozza F, Frank PG, Zhu L, Pestell RG and Lisanti MP: Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism. Mol Biol Cell. 12:2229–2244. 2001. View Article : Google Scholar : PubMed/NCBI

41 

Hartel FV, Holl M, Arshad M, Aslam M, Gündüz D, Weyand M, Micoogullari M, Abdallah Y, Piper HM and Noll T: Transient hypoxia induces ERK-dependent anti-apoptotic cell survival in endothelial cells. Am J Physiol Cell Physiol. 298:C1501–C1509. 2010. View Article : Google Scholar : PubMed/NCBI

42 

World Medical Association Declaration of Helsinki: Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc Res. 35:2–3. 1997.

43 

Zhao Y, Yu L, Xu S, Qiu F, Fan Y and Fu G: Down-regulation of connexin43 gap junction by serum deprivation in human endo-thelial cells was improved by (-)-Epigallocatechin gallate via ERK MAP kinase pathway. Biochem Biophys Res Commun. 404:217–222. 2011. View Article : Google Scholar

44 

Li B, Jia S, Yue T, Yang L, Huang C, Verkhratsky A and Peng L: Biphasic regulation of Caveolin-1 gene expression by fluoxetine in astrocytes: Opposite effects of PI3K/AKT and MAPK/ERK signaling pathways on c-fos. Front Cell Neurosci. 11:3352017. View Article : Google Scholar : PubMed/NCBI

45 

Braet K, Vandamme W, Martin PE, Evans WH and Leybaert L: Photoliberating inositol-1,4,5-trisphosphate triggers ATP release that is blocked by the connexin mimetic peptide gap 26. Cell Calcium. 33:37–48. 2003. View Article : Google Scholar : PubMed/NCBI

46 

Leybaert L, Braet K, Vandamme W, Cabooter L, Martin PE and Evans WH: Connexin channels, connexin mimetic peptides and ATP release. Cell Commun Adhes. 10:251–257. 2003. View Article : Google Scholar : PubMed/NCBI

47 

Nandigama R, Padmasekar M, Wartenberg M and Sauer H: Feed forward cycle of hypotonic stress-induced ATP release, puri-nergic receptor activation, and growth stimulation of prostate cancer cells. J Biol Chem. 281:5686–5693. 2006. View Article : Google Scholar

48 

Galbiati F, Volonte D, Engelman JA, Watanabe G, Burk R, Pestell RG and Lisanti MP: Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperac-tivate the p42/44 MAP kinase cascade. EMBO J. 17:6633–6648. 1998. View Article : Google Scholar : PubMed/NCBI

49 

Park H, Go YM, St John PL, Maland MC, Lisanti MP, Abrahamson DR and Jo H: Plasma membrane cholesterol is a key molecule in shear stress-dependent activation of extracellular signal-regulated kinase. J Biol Chem. 273:32304–32311. 1998. View Article : Google Scholar : PubMed/NCBI

50 

Engelman JA, Chu C, Lin A, Jo H, Ikezu T, Okamoto T, Kohtz DS and Lisanti MP: Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett. 428:205–211. 1998. View Article : Google Scholar : PubMed/NCBI

51 

Chambard JC, Lefloch R, Pouysségur J and Lenormand P: ERK implication in cell cycle regulation. Biochim Biophys Acta. 1773:1299–1310. 2007. View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Arshad M, Conzelmann C, Riaz MA, Noll T and Gündüz D: Inhibition of Cx43 attenuates ERK1/2 activation, enhances the expression of Cav‑1 and suppresses cell proliferation. Int J Mol Med 42: 2811-2818, 2018.
APA
Arshad, M., Conzelmann, C., Riaz, M.A., Noll, T., & Gündüz, D. (2018). Inhibition of Cx43 attenuates ERK1/2 activation, enhances the expression of Cav‑1 and suppresses cell proliferation. International Journal of Molecular Medicine, 42, 2811-2818. https://doi.org/10.3892/ijmm.2018.3828
MLA
Arshad, M., Conzelmann, C., Riaz, M. A., Noll, T., Gündüz, D."Inhibition of Cx43 attenuates ERK1/2 activation, enhances the expression of Cav‑1 and suppresses cell proliferation". International Journal of Molecular Medicine 42.5 (2018): 2811-2818.
Chicago
Arshad, M., Conzelmann, C., Riaz, M. A., Noll, T., Gündüz, D."Inhibition of Cx43 attenuates ERK1/2 activation, enhances the expression of Cav‑1 and suppresses cell proliferation". International Journal of Molecular Medicine 42, no. 5 (2018): 2811-2818. https://doi.org/10.3892/ijmm.2018.3828
Copy and paste a formatted citation
x
Spandidos Publications style
Arshad M, Conzelmann C, Riaz MA, Noll T and Gündüz D: Inhibition of Cx43 attenuates ERK1/2 activation, enhances the expression of Cav‑1 and suppresses cell proliferation. Int J Mol Med 42: 2811-2818, 2018.
APA
Arshad, M., Conzelmann, C., Riaz, M.A., Noll, T., & Gündüz, D. (2018). Inhibition of Cx43 attenuates ERK1/2 activation, enhances the expression of Cav‑1 and suppresses cell proliferation. International Journal of Molecular Medicine, 42, 2811-2818. https://doi.org/10.3892/ijmm.2018.3828
MLA
Arshad, M., Conzelmann, C., Riaz, M. A., Noll, T., Gündüz, D."Inhibition of Cx43 attenuates ERK1/2 activation, enhances the expression of Cav‑1 and suppresses cell proliferation". International Journal of Molecular Medicine 42.5 (2018): 2811-2818.
Chicago
Arshad, M., Conzelmann, C., Riaz, M. A., Noll, T., Gündüz, D."Inhibition of Cx43 attenuates ERK1/2 activation, enhances the expression of Cav‑1 and suppresses cell proliferation". International Journal of Molecular Medicine 42, no. 5 (2018): 2811-2818. https://doi.org/10.3892/ijmm.2018.3828
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team